ID28451A - Trisiklik piperidin-δ3 sebagai bahan farmasi - Google Patents

Trisiklik piperidin-δ3 sebagai bahan farmasi

Info

Publication number
ID28451A
ID28451A IDW20010779A ID20010779A ID28451A ID 28451 A ID28451 A ID 28451A ID W20010779 A IDW20010779 A ID W20010779A ID 20010779 A ID20010779 A ID 20010779A ID 28451 A ID28451 A ID 28451A
Authority
ID
Indonesia
Prior art keywords
triciclic
piperidin
pharmaceutical material
pharmaceutical
Prior art date
Application number
IDW20010779A
Other languages
English (en)
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Mirielle Braeken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID28451A publication Critical patent/ID28451A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW20010779A 1998-10-06 1999-10-01 Trisiklik piperidin-δ3 sebagai bahan farmasi ID28451A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203371 1998-10-06

Publications (1)

Publication Number Publication Date
ID28451A true ID28451A (id) 2001-05-24

Family

ID=8234192

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010779A ID28451A (id) 1998-10-06 1999-10-01 Trisiklik piperidin-δ3 sebagai bahan farmasi

Country Status (28)

Country Link
US (1) US6352999B1 (id)
EP (1) EP1119570B1 (id)
JP (1) JP4590102B2 (id)
KR (1) KR20010071844A (id)
CN (1) CN1131868C (id)
AR (1) AR023679A1 (id)
AT (1) ATE269337T1 (id)
AU (1) AU759199B2 (id)
BG (1) BG64871B1 (id)
BR (1) BR9913108A (id)
CA (1) CA2346082C (id)
CZ (1) CZ20011105A3 (id)
DE (1) DE69918148T2 (id)
EE (1) EE04680B1 (id)
ES (1) ES2222735T3 (id)
HK (1) HK1038009A1 (id)
HU (1) HUP0103749A3 (id)
ID (1) ID28451A (id)
IL (2) IL142444A0 (id)
NO (1) NO20011402D0 (id)
NZ (1) NZ510116A (id)
PL (1) PL347179A1 (id)
RU (1) RU2226194C2 (id)
SK (1) SK285386B6 (id)
TR (1) TR200100953T2 (id)
TW (1) TWI244485B (id)
UA (1) UA70961C2 (id)
WO (1) WO2000020423A1 (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
WO2003004501A2 (en) * 2001-07-05 2003-01-16 Pharmacia & Upjohn Company (hetero) aryl substituted benzofurans as 5-ht ligands
EP1490338B1 (en) * 2002-04-03 2011-08-24 Orion Corporation Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
WO2005100355A1 (ja) 2004-04-12 2005-10-27 Taisho Pharmaceutical Co., Ltd. 環状アミン化合物
AR052674A1 (es) 2005-02-17 2007-03-28 Wyeth Corp Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilcondensados
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
ES2897946T3 (es) * 2013-07-25 2022-03-03 Dong A St Co Ltd Método para preparar un derivado de benzamida, intermedio novedoso utilizado en la preparación de la benzamida y método para preparar un intermedio novedoso
CN103755715B (zh) * 2013-12-26 2015-12-09 武汉理工大学 苯并呋喃并[2,3-c]吡啶化合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
JP2002504088A (ja) * 1996-12-06 2002-02-05 アボツト・ラボラトリーズ ベンゾピラノピロール及びベンゾピラノピリジンアルファ−１アドレナリン作用性化合物
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ

Also Published As

Publication number Publication date
JP2002526547A (ja) 2002-08-20
TR200100953T2 (tr) 2001-09-21
SK4332001A3 (en) 2001-12-03
NZ510116A (en) 2002-10-25
JP4590102B2 (ja) 2010-12-01
SK285386B6 (sk) 2006-12-07
CA2346082C (en) 2010-02-16
KR20010071844A (ko) 2001-07-31
IL142444A0 (en) 2002-03-10
EP1119570B1 (en) 2004-06-16
ATE269337T1 (de) 2004-07-15
HUP0103749A2 (hu) 2002-02-28
EP1119570A1 (en) 2001-08-01
UA70961C2 (uk) 2004-11-15
CN1321158A (zh) 2001-11-07
AU6334299A (en) 2000-04-26
HUP0103749A3 (en) 2003-03-28
CZ20011105A3 (cs) 2001-12-12
EE200100210A (et) 2002-06-17
HK1038009A1 (en) 2002-03-01
CA2346082A1 (en) 2000-04-13
EE04680B1 (et) 2006-08-15
BR9913108A (pt) 2001-05-08
DE69918148D1 (de) 2004-07-22
RU2226194C2 (ru) 2004-03-27
IL142444A (en) 2008-03-20
NO20011402L (no) 2001-03-20
DE69918148T2 (de) 2005-07-28
BG64871B1 (bg) 2006-07-31
AU759199B2 (en) 2003-04-10
TWI244485B (en) 2005-12-01
PL347179A1 (en) 2002-03-25
US6352999B1 (en) 2002-03-05
AR023679A1 (es) 2002-09-04
NO20011402D0 (no) 2001-03-20
ES2222735T3 (es) 2005-02-01
WO2000020423A1 (en) 2000-04-13
CN1131868C (zh) 2003-12-24
BG105334A (en) 2001-11-30

Similar Documents

Publication Publication Date Title
DE29904872U1 (de) Verpackungsmaterial
ID27415A (id) Komposisi farmaseutik
DE69827987D1 (de) Verpackungsmaterial
DE60038253D1 (de) Verbindungsmaterial
ID29262A (id) Komposisi farmasi
DK1466615T3 (da) Farmaceutisk præparat
DE69922710D1 (de) Gasadsorbierendes material
ID27996A (id) Polimorf dari suatu bahan farmasi
ID27150A (id) Sediaan levotiroksin bahan farmasi
FI972210A (fi) Hiostamaton materiaali
EE9900545A (et) Farmatseutiline kompositsioon
ID29294A (id) Komposisi farmasi
FI974634A0 (fi) Anordning foer matning av material
DE69803996T2 (de) Verpackungsmaterial
ID28451A (id) Trisiklik piperidin-δ3 sebagai bahan farmasi
ID25857A (id) Komposisi farmasi
NO991727D0 (no) Materialutlegger
ID26215A (id) Komposisi farmasi
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
DE29722293U1 (de) Verpackungsmaterial
NO20013232L (no) Faststoffmateriale
DE860371T1 (de) Verpackungsmaterial
ID23531A (id) Komposisi farmasi
DE29807443U1 (de) Verpackungsmaterial
SE9804128D0 (sv) A new pharmaceutical composition